Rubia, Aninias S.
HRN: 16-79-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/10/2023
07/16/2023
IVTT
2.25 G
Q6
Cap; Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes